Health management program from Practice Fusion and Merck encourages vaccine uptake
Cloud-based electronic record service Practice Fusion and pharma giant Merck & Co (NYSE: MRK) have collaborated on a project designed to improve public health outcomes through a population health management program for adult vaccines.
The program launched in April and contributed to a statistically significant relative increase in recorded vaccinations among eligible patients on Practice Fusion’s electronic health record platform.
The public health management platform divided over 20,000 healthcare providers into intervention and control group, and recorded patient visits involved patients over the age of 18. In the four-month test period, Practice Fusion observed a 1.1% increase in the test group against a 0.64% increase in the control group in recorded vaccinations.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
| Headless Content Management with Blaze